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TheCarcinogenic Potency Database (CPDB)is aneilyaccibl, r"d resourceofpoditveandnegativelong-
tennanimal cancertest TheCPDB hasbeenpulid nfourearie papersthatinluderesultsfor poi y 4000
experimentson1050chemi ThispaperdescribestheCPDB:goals,indusmoncriteria, ieldsofinfonnation,andpub-
lishedplotformat. ItalsopresentsanoverviewofourpublishedpapersUsingtheCPDB.TheCPDBaspublishedinplot
format readily permitscomparisonsofcarcinogenic potencyandmanyotheraspectsofcancertests, indudingforeach
experiment thespeciesandstrainoftestanimal,therouteanddurationofcompoundadm on, doseleve andother
aspects ofexperimental protocol, histopathology and tumor incidence, ¶D1, (carcinogenic potency) and its statistical
significance, doseresponse,author'sopinionaboutcarcinogenity, andlitersturedtaton. Acombinedplotofailresults
fromthefourseparatepapers, whichisorderedalpbetical bychemical, isavalablefromL. S. Gold,inprintedform
oroncomputertapeordiskette. Acomputerreadable (SAS)database isalsoavailable.
Theoverviewofpapersincludesdescriptionsofworkonmethodsofe tingcarcinogenic poteng, reproducibility
ofresultsinnear-replicatecancertests,correlation in potency betweenspeces, ranking posdblecarcinogenic hazards,
comparison ofpositivity andtarget organ in rats and mice, comparison ofmutagens and nonmutagens, proportion of
chemicals positive in animal tests, natural compared to synthetic chemicals, and mechanistic issues in interspecies
extrapolation.
Description ofthe Carcinogenic
Potency Database
Background
DevelopmentoftheCarcinogenic Potency Database (CPDB)
began more than a decade ago. Experimental protocols of
chronic animal cancer tests as well as the type ofinformation
reportedby scientistsintheliteraturearequitediverse, andthe
large body ofpublished results was not easily accessible. Our
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goals indeveloping the CPDB included: a) to providea stand-
ardized resourceofpositiveandnegativelong-term tests sothat
resultscouldbecompared; b)toprovideestimatesofasinglein-
dexofcarcinogenicpotency foralargenumberofsubstances so
thatrodentpotency couldbecompared toother factors such as
mutagenicity, teratogenicity, chemicalstructure, andhumanex-
posure; c) toprovide easy access to results in printed form; d)
to report detailed information on each experiment including
qualitativeinformationonstrain, sex, targetorgan, histopatho-
logyandauthor'sopinion, aswellasquantitative informationon
statistical significance, tumor incidence, dose-response curve
shape, lengthofexperiment, doserate, anddurationofdosing;
ande)tousethedatabasetoinvestigateimportantissuessuchas
reproducibility ofresults, correlations incarcinogenic potency,
proportionsofchemicalsthatarecarcinogenic, andprediction
ofpositivity andtargetorganbetween species.GOLD ETAL.
The CPDBhas beenpublished in fourpapers inplot format
(1-4) and is awidely used, standardized resourceofresults on
approximately 4000 experiments of 1050 chemicals that were
reportedeitherinthegeneralliteratureorintechnicalreportsof
the National Cancer Institute/National Toxicology Program
(NCI/NTP). We are continuing to update the CPDB and have
also prepared a combined plot that merges all earlier results
organizedbychemical; thecombinedplotcanbeobtainedfrom
L. S. Gold in eitherprintedform, ondiskette, ortape. A com-
puter readable (SAS) database is alsoavailable.
Inclusion Rules
Ourstandardinclusioncriteriaaredesignedtoidentifyforthe
CPDBreasonablythorough, chroniclong-termteststhatpermit
the estimation ofcarcinogenic potency; therefore, reasonable
consistency ofexperimentalprotocols isassured. Bioassaysare
included only ifthey meetthe criterialisted in Table 1.
TheTD5s
TheTD50isournumericalindexofpotencyandhasbeenfully
described (1,5,6). TheTD50 may bebriefly definedas follows:
foragiventargetsite(s), iftherearenotumorsincontrolanimals,
thenTD50isthatchronicdoserateinmilligrams/kilogrambody
weight/daythatwould induce tumorsinhalfthetestanimalsat
theendofastandardlifespanforthespecies. Sincethetumor(s)
of interest often does occur in control animals, TD50 is more
precisely defined as that chronic dose rate that will halve the
probability of remaining tumor-free throughout the standard
lifespan. OnereasonforchoosingtheTD50wasthatitiseasyto
understandthe concept, particularlybecauseoftheanalogy to
theLD50. Importantly, theTD5oisoftenwithintherangeofdoses
tested; thus the experimental results do not have to be ex-
trapolated far toestimateTD5o. The rangeofstatisticallysignifi-
cant TD50 values for carcinogens in the CPDB is morethan 10
millionfold (1).
Plot Format and Features
AdetailedguidetotheplotoftheCPDBwasincludedinGold
etal. (1); itdescribedthe contents, fieldbyfield, anddiscussed
sources ofdata, criteria for inclusionofparticulartargetsites,
andconventionsadoptedinsummarizingtheliterature. Foreach
Table 1. Criteria for inclusion in the Carcinogenic Potency Database.
Animals on test were mammals
Administration wasbegunearly in life
Routeofadministration wasdiet, water, gavage, inhalation, intravenous orin-
traperitoneal injection(i.e., wherethe wholebody was morelikely to have
beenexposed ratherthanonly aspecificsite, as with subcutaneousinjec-
tion or skinpainting)
Testagent wasadministeredalone, ratherthan incombinationwithother
chemicals
Exposure was chronic, with less than 8 daysbetweendoses
Duration ofexposure was at least one-fourth the standard lifespan for that
species
Duration ofexperiment was at least halfthe standard lifespan forthat species
Researchdesign included a control group
Researchdesign included at least five animals pergroup
Surgical intervention was notperformed
Authorreported numberofanimals with tumor, not number oftumors
Results reported wereoriginal data, not secondary analyses
experimentintheCPDB,aTD50isreportedwheneverdocumen-
tation in the original paper is adequate for: a) each target site
evaluatedbytheauthorastreatmentrelated; b) eachsitewitha
statisticallysignificantresult; c)alltumor-bearinganimals;d)
dataonliverandalsoonlungformice. Itemscanddare "man-
datory sites." Appendicesfollowingtheplotfacilitateidentifica-
tionofchemicals by name, synonyms, and CAS number; they
also define codes for strains, routes of administration, sites,
histopathology, author's opinions, dose-response curve sym-
bols; andliteraturereferences. Asampleoftheplotanddescrip-
tion foroneexperiment is given in Figure 1.
AuniquenumberisassignedtoeachexperimentintheCPDB
plot, and lowercase letters for subsequent lines identify each
TD5ocalculatedforthatexperiment. Thenumberinsertedabove
eachfield inFigure 1 corresponds tothedescriptionbelow. [1]
Chloroform is thechemical; [2] R: species is rat; [3] m: sex is
male; [4] osm: strainis Osborne-Mendel; [5] gav: routeofad-
ministration is gavage; [6] kid: site is kidney; [7] MXA:
histopathology is amixoftumortypescombinedby NCI. The
pathology is indicated on the right side ofthe plot under [27]
wherethecodesare "kid:tla, uac," indicatingamixoftubular-
cell adenoma and tubular-cell adenocarcinoma. The site and
histopathology is reported in the nomenclature used in the
originalpublishedpaperortechnicalreport. [8] 18m: lengthof
exposure is 18 months; [9] 26m: length of experiment is 26
months. [10] "Notes" isblankherebutisusedtodescribepar-
ticularssuchassurvivalproblemsorvariabledosingschedules.
[11] LogarithmicscaleforTD50andconfidencelimits. [12] The
plotted TD50 value with the symbol "+" indicating that the
statistical significance ofthe TD50 isp < 0.01. The colon in-
dicatesthe99% confidencelimitsforTD50andshowsthatTD50
wascalculatedwithlifetabledata; [13] 119.mg: valueofTD50in
milligrams/kilogram/day. [14] Shapeofthedose-responsecurve,
determinedbyatestfordeparturefromlinearity. Thesolidus(/)
indicates significantdeparturefromlinearitywithupwardcur-
vature. [15] p < 0.0005: two-tailed p-value associated with
testingwhethertheslopeofthedose-responsecurveisdifferent
fromzero. [16]c: NCIopinionthatchloroformwascarcinogenic,
inducingthetumorsindicatedunder [6] and [7]. Therightside
oftheplotrepeatsas [17] theexperimentnumber. [18] 67-66-3:
CAS registry number for chloroform; [19] c02686: unique
reference number for a paper or an NCI/NTP identification
number; [20-21] 65.5mg and 334.mg: lower and upper con-
fidencelimitsfortheTD50inmilligrams/kilogram/day. [22-26]
Proportion ofanimals with tumors in [6-7] and average daily
doserateinmilligrams/kilogram/day forthecontrolgroupand
eachdosegroup. ForNCI/NTPthedenominatorindicates the
starting number of animals, and the numerator indicates the
number ofanimals with tumors by the end ofthe experiment.
[27] CodesforhistopathologyforNCI/NTPandliteraturecita-
tionforpaperspublishedinthegeneralliterature. Linesaandb
underthis experimentgive results formandatory sites that are
always included in the database whenever data are available.
TBA: alltumor-bearinganimals; andliv: liver. Futherdetailson
theplotaregiven inGoldetal. (1).
Tofacilitateaccesstobioassayresultsforresearchersinterested
inaparticulartargettissue(e.g., forstudiesofmechanism, com-
parative toxicology and histopathology, orepidemiology), we
recentlypreparedacompendiumorganizedby targetorganfor
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Spe Strain Site Xpo+Xpt
Sex Route Hist Notes
1l] [2][33E[4[5][61 [7] [8l E 9t103
CHLOROFORM***
I R . osm gav kid MXA 18.26
a R a osm gav TBA MXB 18.26
b R m osa gav Liv MXB 18.26
Left side of database plot.
[11] [12]
TDS0 2Taitpvl
DR AuOp
[131 C14]E15lt16l
lOOng..:. .lug. : 10. :100.. g :. . :10. :100.. . : . : 10
: + : 119..g / P<.0005c
194..g * P<.5
455.mg * P<.08
Citation or Pathology RefNum LoConf UpConf Cntrl IDose lInc 2Dose ZInc
[17][18l[19] [20] [213 [22] [23] E24] [25] [26] [27l
Brkly Code
CHLOROFORM*** 67-66-3
1 c02686 65.5mg 334.mg
a c02686 43.5mg n.s.s.
b c02686 157.mg n.s.s.
Right side of database plot.
0/20 45.2ag 4/50 90.3mg 12/50
9/20 45.Zg 24/50 90.3ag 20/50
0/20 45.2g 1/50 90.3mg 3/50
FIGURE 1. Sample plot for one experiment in theCarcinogenic Potency Database.
522chemicals that arecarcinogenic inatleast onespecies. The
compendium canbe used to identify quickly all chemicals that
induce tumors at aparticular siteand todeterminewhethertarget
sites are the same for chemicals positive in more than one
species. Chemical carcinogens are reported for 35 different
target organs. Overall, 94% ofmousecarcinogens and 83% of
ratcarcinogens arepositive in atleastoneoftheeight mostfre-
quent target sites: liver, lung, mammary gland, stomach, vas-
cular system, kidney, hematopoietic system, and urinary blad-
der (7).
Some general characteristics of the CPDB are as follows:
Amongthe 1050chemicals, 427 havebeentestedinboth ratsand
mice, and 270 havebeentested by NCI/NTP. Tests arealso in-
cluded onhamsters, dogs, andmonkeys. Results areincluded on
96 different mouse strains and 72 rat strains. In the CPDB the
numberofexperiments perchemical varies, and somechemicals
are morethoroughlytestedthanothers. Thepercentageswith one
experiment, two experiments, and more than two experiments
are30, 52, and 18%, respectively, for ratsand 12, 56, and32%,
respectively, for mice.
Overview of Our Published Papers
Using the Carcinogenic Potency
Database
WehaveusedtheCPDB toaddress many issuesrelevantto car-
cinogenesis and interspecies extrapolation. We summarize this
work below and refer the reader to the published papers.
With respect tothe measurement ofcarcinogenic potency, we
first compared two methods for estimating TD50 from animal
bioassays, onebased on lifetabledataand onebased on summary
incidence data (8). There is substantial agreeement between
thesemethods, although lifetable estimates areusually more po-
tent. ThissimilarityprovidesconfidenceinTD50estimatesbased
only on summarydata, which areall that areusually available in
theliterature. Second, wehave shownthatthepotency calculated
fromexperimental results (giventheusualexperimental design
and the lack of 100% tumor incidence in dosed animals) is
restricted to an approximately 30-fold range surrounding the
maximum dose tested in a standard bioassay (9). Third, for
chemicalsthat arepositivein morethan one testinaspecies, the
most potentTD50value from among allpositive tests is smiliar
toother measures that averageTD5ovalues orfunctionsofvalues
(harmonic mean, geometric mean, or arithmetic mean).
However, for 18 chemicals in ratsand 12 inmice, theminimum
TD5oestimatediffers fromthemaximumestimateby morethan
afactorof10; fortheserelatively fewcarcinogens, any summary
measureofpotency masksthevariation acrossexperiments (10).
Using the mostpotentTD.oin ratsandmice, wehavepublished
a concise tabulation oftheTD_o for positive chemicals, which
also includes a summaryoftheevaluations as tocarcinogenici-
ty in each sex-species group (10).
Correlation studies ofcarcinogenic potency have been con-
ducted. Wehavediscussed sometautologous aspects ofthegood
correlation in potency between rats and mice (9) and have
reported a weak association of mutagenic potency and car-
cinogenic potency for 80 chemicals that are both mutagenic in
Salmonella and carcinogenic in rats or mice (11).
A single measure ofpotency like TD50 can summarize only
someoftheinformation from acarcinogenesisbioassay. Wehave
investigated other indicators of a chemical's hazard using the
NCI/NTPbioassays, i.e., whether tumors wereinduced at more
than onesite, whether tumors may havecausedthedeathofthe
animal or werefound atsacrifice, andwhethermetastasesofin-
duced tumorsoccurred (12). Thesehazard indicators are some-
timesinterrelated; however, theTD5ovaluesofchemicalsthat are
hazardous by each ofthese measures span a wide range. Car-
cinogens thatinduced sometypeoffatal tumor were more like-
lythanothercarcinogens toinducetumors inmultiple organsites
andmultiplesex-species groups. Theseotherindicators should
be used with potency estimates to summarize and compare
results on chemical carcinogens.
Reproducibility of results in animal bioassays has been in-
vestigated in near-replicate comparisons consisting of two or
more tests ofthe samechemical administeredby the same route
usingthe same sexand strainofrodent(13). Wehaveupdatedthis
analysis and continue to find that overall in the CPDB there is
kid:tla,uac.
l iv:hpa,hpc,nnd.
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goodreproducibility ofpositivity, targetsite, andTD50. Among
116comparisonsonly 14% (16/116) havediscordantauthor'sopin-
ions about whether tumors were induced in the individual ex-
periments. Inallbut3 ofthe62positivecomparisons, atleast 1
targetsiteisidentical inallofthenear-replicatetests. TheTD50
values were within a factor of 2 of each other in 54% of the
positive comparisons, within afactorof4 in 81%, andwithina
factor of 10 in 91%.
We have proposed a rough index of possible carcinogenic
hazard to humans, HERP (human exposure/rodent potency),
which compares for a given chemical the chronic dose rate at
which humans are exposed (milligrams/kilogram/day) to the
TD50 in rodents. We havecomputed HERPvalues foravariety
ofsynthetic andnaturallyoccurring substances towhichpeople
may be exposed and have constructed a scale to rank possible
hazards. This ranking suggests thatcarcinogenic hazards from
currentlevelsofpesticideresidues orwaterpollution arelikely
to be ofminimal concern relative to the background levels of
natural substances, thoughonecannot say whetherthesenatural
exposures are likely to be of major or minor importance in
human cancer (14-20). In a separate analysis, a similar index,
PERP (permitted exposure/rodent potency) was calculated us-
ing theU.S. Occupational SafetyandHealthAdministrationper-
mitted exposure limit (OSHA PEL), assuming adaily lifetime
exposure at that limit. From among approximately 500 com-
pounds in the CPDB that are rodent carcinogens and approx-
imately 500 that are regulated with PELs by OSHA, only 41
compounds arecommontoboth. ThePERPvaluesrangemore
than 100,000-fold for exposures to different substances at the
PEL. Forsomesubstances, exposuresatthePELwouldbeclose
tothedoseratethatproduces tumorsin50% oftestanimals (21).
Wehavecomparedresults formutagensandnonmutagensus-
ingevaluations inSalmonellafromthedatabases oftheNTPand
theU.S. Environmental Protection AgencyGene-ToxProgram.
Overall, mutagens are more often carcinogenic than non-
mutagens; however, morethan40% ofcarcinogenstestedinrats
and mice are not mutagenic; 28% ofnoncarcinogens are mu-
tagens that presumably are not acting as mutagens in rodents.
Among carcinogens in rats ormice, achemical positive in one
species is morelikely tobepositive inthesecondspeciesifitis
amutagen. Additionally, weexaminedtheassociationbetween
mutagenic response andadministereddoselevel inpositive ro-
denttestsandfoundthatmoretoxiccarcinogensaresignificantly
more likely tobe mutagenic than less toxic carcinogens (22).
Wehavestudiedtheproportionofchemicalsthatarepositive
amongthosereportedintheCPDBfor 10differentdata sets: all
chemicals, NCI/NTPchemicals, NCIchemicals reportedbefore
1979, literatureotherthanNCI/NTP, chemicalstestedinbothrats
andmice(andamongthese, naturalchemicalsonlyandsynthetic
chemicals only), natural pesticides, mold toxins, and 22
chemicals incoffee. Ineachcase, roughlyhalfofthechemicals
arepositiveaccording tothepublishedauthor'sopinioninatleast
one test (14,22-25). Among chemicals tested formutagenicity
as well as for carcinogenicity in both rats and mice, three-
quarters areeithermutagens orcarcinogens. Wehavepostulated
thatthe administration ofchemicals atthe maximum tolerated
dose(MTD)instandardanimalcancertests increasescelldivi-
sion(mitogenesis), whichinturn increases ratesofmutagenesis
and thus carcinogenesis (23,25-29). A variety of studies on
mechanism ofcarcinogenesis are consistent withthis explana-
tion (23). Weconcludethatatthelowdosesofmosthuman ex-
posures wherecell killing doesnotoccur, thehazardstohumans
of rodent carcinogens may be much lower than is commonly
assumed.
The natural world makes up the vast bulk ofchemical that
humansconsumeeachdayinbothweightandnumber. Sincehalf
ofnatural chemicals (as well as halfthe natural pesticides) are
positive in animal tests, weconclude thatourdietis filled with
rodent carcinogens as defined by high-dose tests. The tox-
icological significance ofexposures to synthetic chemicals has
beenexaminedinthecontextofexposurestonaturally occuring
chemicals, and we arguethatanimals have abroad array ofin-
duciblegeneraldefensesthatatlow-doseexposures areeffective
againstbothnatural and synthetic toxins (24,30). Thehighpro-
portionofpositive resultsincancertestsofbothnaturaland syn-
thetic chemicals and the similarity in their toxicology call into
questionthecurrentefforts toprotectpublic healthby focusing
regulatory action on synthetic chemicals.
The issue of extrapolating carcinogenesis results from one
species toanotherhasbeenaddressedintwoanalysesofpredic-
tionbetweentwocloselyrelatedspecies, ratsandmice. Wehave
examined howwell onecanpredictcarcinogenicity from rats to
miceandfrommicetoratsanddiscussthreefactorsthataffectthe
accuracy ofpredicction: chemical class, mutagenicity, and the
dose level at which a chemical is toxic. Additionally, we have
describedthefrequency ofacarcinogenic response ineachtarget
organ and have determined the predictive value of individual
target sites in one species for carcinogenicity in the second
species (7,22).
Overall forratsandmice, knowingthatachemical ispositive
inoneofthespeciespredictspositivity intheotherspeciesabout
75% ofthetime. Theoverallpredictivevaluesbetweenratsand
mice provide some confidence in interspecies extrapolation;
however, since ahigh proportion oftestchemicals are positive
bychance alonewewouldexpectapositivepredictivevaluebe-
tween speciesofabout50% (7,22). Site-specific predictionbe-
tween rats and mice is less accurate than overall prediction of
positivity. Knowingthatachemicalispositiveatany siteinone
species gives about a50% chancethat itwill bepositive at the
same site intheother species. Because many chemicals induce
tumors atmultiple sites, thereisoftenmorethanonetarget site
thatispotentially acommonsiteforthetwospecies. Amongthe
101 chemicalswithasiteincommonbetweenratsandmice, for
45 chemicals the liver is the only site in common (7).
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